
Boehringer Ingelheim will kick off its pharma investments in 2016 with a half a billion Euro outlay and plans to …

Sandoz has opened a €150m state-of-the-art biopharmaceutical manufacturing facility in Schaftenau, Austria. Known as BioInject will result in the creation …

Boehringer Ingelheim has said it plans to invest around €17 million in its biopharmaceutical development and manufacturing capabilities at Biberach, …

